GHISLAINE MAXWELL ACCT. For the Period 1/1/12 to 1/31/12 Account Summary Asset Allocation Beginning Ending Change Estimated Current Asset Allocation Market Value Market Value in Value Annual Income Allocation Equity 1,414,900.54 1,123,837.25 (291,063.29) 46,954.44 13% Alternative Assets 44,424.00 189.792.46 145,368.46 2% Cash 8 Fixed Income 3,383,938.21 7,258,799.86 3,874861.65 58,748.29 84% Other 83.641 54 88.373 68 4.732.14 1% Market Value Accruals 54.926.904.29 $8.660.803.25 $3.733.898.96 27,584 20 32 695 68 5.111 48 4105.702.73 100% Market Value with Accruals 54.954.488.49 58.693.498.93 $3.739.010.44 Portfolio Activity Current Year-to•Date Period Value Value Beginning Market Value 4,926,904.29 4,926,904.29 Contributions Withdrawals 8 Fees Secunties Transferred In 4,972,799.54 4,972,799.54 (1,522,802.63) (1,522,802.63) 2,449,604.12 2,449,604.12 Securities Transferred Out (2,347,535.86' (2.347.535.86 Net ContributIons/Withdrawals Income 8 Distributions $3,662,065.17 $3,662,066.17 9,121.64 9,121.64 Change in Investment Value 172,712 15 172.712 15 Ending Market Value Accruals 58.660.803.25 0.660.803.25 32.695 68 32 695 68 Market Value with Accruals $8.693.498.93 $8.693.498.93 JP Morgan Orliet Arternarive Auras Equity Page 2 of 50 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00048357 SDNY_GM_00317555 EFTA01521004